Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Beguin

Showing results (91-100 of 243) with videos related to

Pageof 25
Sort By:
Contrast Media & Molecular Imaging|November 4, 2017
A First Report on [<sup>18</sup>F]FPRGD<sub>2</sub> PET/CT Imaging in Multiple MyelomaNadia Withofs, François Cousin, Bernard De Prijck, et al.
Stem Cells (Dayton, Ohio)|April 15, 2006
Despite inhibition of hematopoietic progenitor cell growth in vitro, the tyrosine kinase inhibitor imatinib does not impair engraftment of human CD133+ cells into NOD/SCIDbeta2mNull miceLaurence Pirson, Frédéric Baron, Nathalie Meuris, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 12, 2014
Mesenchymal stromal cell therapy in conditions of renal ischaemia/reperfusionPauline Erpicum, Olivier Detry, Laurent Weekers, et al.
Leukemia & Lymphoma|May 9, 2012
Panhypopituitarism and diabetes insipidus in a patient with primary central nervous system lymphomaOlivier Malaise, Nicolas Frusch, Emmanuel Beck, et al.
Cytotherapy|June 8, 2010
Effects of granulocyte-colony-stimulating factor on progenitor cell mobilization and heart perfusion and function in normal miceMarie Delgaudine, Bernard Lambermont, Patrizio Lancellotti, et al.
Journal of Hematotherapy & Stem Cell Research|May 2, 2002
Nonmyeloablative stem cell transplantation with CD8-depleted or CD34-selected peripheral blood stem cellsFrédéric Baron, Etienne Baudoux, Pascale Frère, et al.
Leukemia & Lymphoma|June 3, 2017
Molecular mechanisms, current management and next generation therapy in myeloma bone diseaseRoy Heusschen, Joséphine Muller, Elodie Duray, et al.
Plos One|May 30, 2009
Impact of growth hormone (GH) deficiency and GH replacement upon thymus function in adult patientsGabriel Morrhaye, Hamid Kermani, Jean-Jacques Legros, et al.
Clinical Orthopaedics and Related Research|January 4, 2020
Did Osteoblastic Cell Therapy Improve the Prognosis of Pre-fracture Osteonecrosis of the Femoral Head? A Randomized, Controlled TrialJean-Philippe Hauzeur, Chantal Lechanteur, Etienne Baudoux, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 29, 2021
Comprehensive analysis of the immunomodulatory effects of rapamycin on human T cells in graft-versus-host disease prophylaxisGrégory Ehx, Caroline Ritacco, Muriel Hannon, et al.
Pageof 25

Showing results (91-100 of 243) with videos related to

Sort By:
Pageof 25
Contrast Media & Molecular Imaging|November 4, 2017
A First Report on [<sup>18</sup>F]FPRGD<sub>2</sub> PET/CT Imaging in Multiple MyelomaNadia Withofs, François Cousin, Bernard De Prijck, et al.
Stem Cells (Dayton, Ohio)|April 15, 2006
Despite inhibition of hematopoietic progenitor cell growth in vitro, the tyrosine kinase inhibitor imatinib does not impair engraftment of human CD133+ cells into NOD/SCIDbeta2mNull miceLaurence Pirson, Frédéric Baron, Nathalie Meuris, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 12, 2014
Mesenchymal stromal cell therapy in conditions of renal ischaemia/reperfusionPauline Erpicum, Olivier Detry, Laurent Weekers, et al.
Leukemia & Lymphoma|May 9, 2012
Panhypopituitarism and diabetes insipidus in a patient with primary central nervous system lymphomaOlivier Malaise, Nicolas Frusch, Emmanuel Beck, et al.
Cytotherapy|June 8, 2010
Effects of granulocyte-colony-stimulating factor on progenitor cell mobilization and heart perfusion and function in normal miceMarie Delgaudine, Bernard Lambermont, Patrizio Lancellotti, et al.
Journal of Hematotherapy & Stem Cell Research|May 2, 2002
Nonmyeloablative stem cell transplantation with CD8-depleted or CD34-selected peripheral blood stem cellsFrédéric Baron, Etienne Baudoux, Pascale Frère, et al.
Leukemia & Lymphoma|June 3, 2017
Molecular mechanisms, current management and next generation therapy in myeloma bone diseaseRoy Heusschen, Joséphine Muller, Elodie Duray, et al.
Plos One|May 30, 2009
Impact of growth hormone (GH) deficiency and GH replacement upon thymus function in adult patientsGabriel Morrhaye, Hamid Kermani, Jean-Jacques Legros, et al.
Clinical Orthopaedics and Related Research|January 4, 2020
Did Osteoblastic Cell Therapy Improve the Prognosis of Pre-fracture Osteonecrosis of the Femoral Head? A Randomized, Controlled TrialJean-Philippe Hauzeur, Chantal Lechanteur, Etienne Baudoux, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 29, 2021
Comprehensive analysis of the immunomodulatory effects of rapamycin on human T cells in graft-versus-host disease prophylaxisGrégory Ehx, Caroline Ritacco, Muriel Hannon, et al.
Pageof 25